CDKAL1 and type 2 diabetes mellitus: We have previously shown that type 2 diabetes risk variants in CDKAL1 and HHEX were associated with decreased beta-cell glucose sensitivity in nondiabetic individuals (24); however, these associations have not been tested in a larger cohort that includes subjects with abnormal glucose tolerance.